Clinical Trials Directory

Trials / Unknown

UnknownNCT02046083

Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of the protocol is to evaluate the efficacy of a protocol for induction of tolerance to peanut ingestion increasing doses. The secondary purpose is to determine the interest of a prolonged maintenance therapy

Detailed description

Prospective randomized double blind, placebo controlled, protocol in two phases: 1/ active treatment versus placebo for induction phase; 2/ long versus short maintenance

Conditions

Interventions

TypeNameDescription
DRUGarachid

Timeline

Start date
2013-07-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2014-01-27
Last updated
2014-01-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02046083. Inclusion in this directory is not an endorsement.